Drug evaluation using patient-derived organoid of HER2-positive salivary duct carcinoma in vitro and in vivo

被引:0
|
作者
Aoyama, Jun [1 ]
Nojima, Yusuke [1 ]
Aizawa, Yoshihiro [1 ]
Takada, Kentaro [1 ]
Kijima, Natsumi [1 ,2 ]
Hirai, Yuri [1 ]
Hatano, Takashi [1 ]
Takahashi, Hideaki [1 ]
Sano, Daisuke [1 ]
Fujii, Satoshi [2 ]
Oridate, Nobuhiko [1 ]
机构
[1] Yokohama City Univ, Dept Head & Neck Surg, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Dept Mol Pathol, Yokohama, Kanagawa, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-1287
引用
收藏
页码:449 / 449
页数:1
相关论文
共 50 条
  • [41] Capecitabine is effective as palliative chemotherapy in a patient with androgen receptor and HER2 positive metastatic salivary duct carcinoma. A case report
    Cavka, Luka
    Zakotnik, Branko
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (07) : 2048 - 2051
  • [42] Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient
    Li, Zhaoqing
    Zhuo, Wenying
    Chen, Lini
    Zhang, Xun
    Chen, Cong
    Hu, Dengdi
    Chen, Yongxia
    Yang, Jingjing
    Zhou, Yulu
    Mao, Misha
    Xu, Ling
    Ju, Siwei
    Shen, Jun
    Wang, Qinchuan
    Dong, Minjun
    Xie, Shuduo
    Zhou, Jichun
    Wang, Linbo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [43] Modeling antibody drug conjugate sensitivity using urothelial carcinoma patient-derived models
    Tang, Xinran
    Chen, Ziyu
    Thomas, Jasmine
    Nagar, Karan
    Christin, John
    Rustgi, Naryan
    Gao, Sizhi
    de Stanchina, Elisa
    Coleman, Jonathan
    Shen, Michael
    Al-Ahmadie, Hikmat
    Iyer, Gopa
    Kim, Kwanghee
    Solit, David
    CANCER RESEARCH, 2024, 84 (06)
  • [44] Identification of new therapeutic targets in penile squamous cell carcinoma using patient-derived in-vitro and in-vivo models
    Linxweiler, J.
    Ayoubian, H.
    Mink, J.
    Pongratanakul, P.
    Skowron, M. A.
    Kotthoff, M.
    Stoeckle, M.
    Nettersheim, D.
    Junker, K.
    EUROPEAN UROLOGY, 2024, 85 : S1417 - S1417
  • [45] Evaluation of the Efficacy of Postoperative Adjuvant Therapy for HER2-Positive Ductal Carcinoma in Situ with Microinvasion
    Xu, Zhihong
    Tao, Dan
    Zhou, Zhibing
    Jiang, Qihua
    Wei, Wensong
    CANCER INVESTIGATION, 2024, 42 (05) : 408 - 415
  • [46] Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
    Ryu, Jin-Sun
    Sim, Sung Hoon
    Park, In Hae
    Lee, Eun Gyeong
    Lee, Eun Sook
    Kim, Yun-Hee
    Kwon, Youngmee
    Kong, Sun-Young
    Lee, Keun Seok
    CANCERS, 2019, 11 (04):
  • [47] Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer
    Yuko Takano
    Satoshi Furune
    Yuki Miyai
    Sachi Morita
    Megumi Inoue
    Tomoya Shimokata
    Mihoko Sugishita
    Ayako Mitsuma
    Osamu Maeda
    Yuichi Ando
    International Cancer Conference Journal, 2022, 11 : 67 - 70
  • [48] Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer
    Takano, Yuko
    Furune, Satoshi
    Miyai, Yuki
    Morita, Sachi
    Inoue, Megumi
    Shimokata, Tomoya
    Sugishita, Mihoko
    Mitsuma, Ayako
    Maeda, Osamu
    Ando, Yuichi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2022, 11 (01) : 67 - 70
  • [49] In vivo evaluation of dacomitinib (PF-00299804) in patient-derived salivary gland tumor models: Identification of a potential treatment options for adenoid cystic carcinoma
    Wick, Michael J.
    Estrada, Vanessa E.
    Nieves, Francis E.
    Kelly, Scott G.
    Tolcher, Anthony W.
    Patnaik, Amita
    Kaufman, Jeffrey
    Pablo Lopez-Casas, Pedro
    Calvo, Emiliano
    Hidalgo, Manuel
    Papadopoulos, Kyriakos P.
    CANCER RESEARCH, 2012, 72
  • [50] Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast
    Usui, Yuki
    Matsunuma, Ryoichi
    Yamaguchi, Kei
    Hayami, Ryosuke
    Muramatsu, Aya
    Suzuki, Makoto
    Tsuneizumi, Michiko
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1536 - 1541